DK0881901T3 - Kombination af aktive stoffer, der indeholder clopidogrel og et antithrombotisk middel - Google Patents

Kombination af aktive stoffer, der indeholder clopidogrel og et antithrombotisk middel

Info

Publication number: DK0881901T3
Authority: DK; Denmark
Prior art keywords: pct; combination; active substances; substances containing; antithrombotic agent
Prior art date: 1996-02-19

Application number

DK97905218T

Other languages

Danish (da)

English (en)

Inventor

Andre Bernat

Jean-Marc Herbert

Pierre Savi

Original Assignee

Sanofi Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-19

Filing date

1997-02-17

Publication date

2002-10-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0881901(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-02-17 Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo

2002-10-07 Application granted granted Critical

2002-10-07 Publication of DK0881901T3 publication Critical patent/DK0881901T3/da

Links

239000005552 B01AC04 - Clopidogrel Substances 0.000 title abstract 2
GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 title abstract 2
229960003009 clopidogrel Drugs 0.000 title abstract 2
239000013543 active substance Substances 0.000 title 1
239000003146 anticoagulant agent Substances 0.000 title 1
229960004676 antithrombotic agent Drugs 0.000 title 1
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
239000000470 constituent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Materials For Medical Uses (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK97905218T 1996-02-19 1997-02-17 Kombination af aktive stoffer, der indeholder clopidogrel og et antithrombotisk middel DK0881901T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9602027A FR2744918B1 (fr)	1996-02-19	1996-02-19	Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
PCT/FR1997/000296 WO1997029753A1 (fr)	1996-02-19	1997-02-17	Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique

Publications (1)

Publication Number	Publication Date
DK0881901T3 true DK0881901T3 (da)	2002-10-07

Family

ID=9489354

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97905218T DK0881901T3 (da)	1996-02-19	1997-02-17	Kombination af aktive stoffer, der indeholder clopidogrel og et antithrombotisk middel

Country Status (28)

Country	Link
US (1)	US5989578A (et)
EP (1)	EP0881901B1 (et)
JP (1)	JP3662028B2 (et)
KR (1)	KR100295345B1 (et)
CN (1)	CN1116042C (et)
AT (1)	ATE218870T1 (et)
AU (1)	AU715655B2 (et)
BR (1)	BR9707556A (et)
CA (1)	CA2246289C (et)
CZ (1)	CZ292363B6 (et)
DE (2)	DE122010000030I2 (et)
DK (1)	DK0881901T3 (et)
EE (1)	EE03513B1 (et)
ES (1)	ES2176684T3 (et)
FR (1)	FR2744918B1 (et)
HU (1)	HU225036B1 (et)
IL (1)	IL125848A (et)
IS (1)	IS1892B (et)
NO (2)	NO317747B3 (et)
NZ (1)	NZ331444A (et)
PL (1)	PL187292B1 (et)
PT (1)	PT881901E (et)
RU (1)	RU2184547C2 (et)
SI (1)	SI0881901T1 (et)
SK (1)	SK284285B6 (et)
TR (1)	TR199801608T2 (et)
UA (1)	UA51695C2 (et)
WO (1)	WO1997029753A1 (et)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2002506024A (ja) *	1998-03-13	2002-02-26	メルクエンドカムパニーインコーポレーテッド	急性冠動脈虚血症候群および関連状態に対する併用療法および組成物
CA2332608C (en)	1998-06-17	2010-03-23	Bristol-Myers Squibb Company	Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
US6509348B1 (en)	1998-11-03	2003-01-21	Bristol-Myers Squibb Company	Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr)	1999-04-30	2001-07-27	Sanofi Sa	Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) *	1999-08-11	2001-02-16	Sanofi Synthelabo	Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
NZ526540A (en) *	2000-12-25	2004-11-26	Sankyo Co	Medicinal compositions containing aspirin and 2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-flurobenzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridine useful in preventing thrombus or embolus diseases
SE0101932D0 (sv) *	2001-05-31	2001-05-31	Astrazeneca Ab	Pharmaceutical combinations
FR2832929A1 (fr) *	2001-12-05	2003-06-06	Sanofi Synthelabo	Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
AU2003270861A1 (en) *	2002-10-02	2004-04-23	Bristol-Myers Squibb Company	Novel combination of a factor xa inhibitor and clopidogrel
ATE536889T1 (de) *	2003-07-08	2011-12-15	Accumetrics Inc	Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten
US20070243632A1 (en) *	2003-07-08	2007-10-18	Coller Barry S	Methods for measuring platelet reactivity of patients that have received drug eluting stents
HUP0400982A2 (en) *	2004-05-17	2006-08-28	Chemor Kutato	New veterinary product for honeybees
US20060222640A1 (en) *	2005-03-29	2006-10-05	Boehringer Ingelheim International Gmbh	New pharmaceutical compositions for treatment of thrombosis
RU2303980C2 (ru) *	2005-06-03	2007-08-10	ОАО "Щелковский витаминный завод"	Лекарственная форма с антиагрегационным действием и способ ее изготовления
CN101253179B (zh) *	2005-09-21	2010-12-29	株式会社钟根堂	S-氯吡格雷的树脂酸盐复合物及其制备方法
WO2008048083A1 (es) *	2006-10-17	2008-04-24	Espinosa Abdala Leopoldo De Je	Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de)	2006-11-02	2008-05-08	Bayer Materialscience Ag	Kombinationstherapie substituierter Oxazolidinone
CN101686681B (zh)	2007-04-27	2015-04-01	锡德克斯药物公司	包含氯吡格雷和磺基烷基醚环糊精的制剂和其使用方法
JP2011512406A (ja) *	2008-02-22	2011-04-21	ハナルバイオファーマカンパニーリミテッド	複合製剤
DE102008032361A1 (de) *	2008-07-10	2010-01-21	Csl Behring Gmbh	Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
WO2010132711A1 (en)	2009-05-13	2010-11-18	Cydex Pharmaceuticals, Inc.	Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
KR20120050437A (ko)	2009-06-25	2012-05-18	테트라, 시아	신규한 아세틸살리실산 염들
WO2011071853A2 (en)	2009-12-07	2011-06-16	Academic Pharmaceuticals Incorporated	Parenteral formulation of clopidogrel
CN102389436A (zh) *	2011-09-09	2012-03-28	北京阜康仁生物制药科技有限公司	一种抗血小板聚集的药物组合物
KR101675501B1 (ko)	2011-11-02	2016-11-14	한국유나이티드제약 주식회사	클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en)	2011-11-26	2013-08-20	Academic Pharmaceuticals, Inc.	Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) *	2011-11-29	2012-04-11	北京阜康仁生物制药科技有限公司	一种抗血栓的药物组合物
WO2013133620A1 (en) *	2012-03-09	2013-09-12	Yuhan Corporation	Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same
CN103720700A (zh) *	2012-10-10	2014-04-16	江苏威凯尔医药科技有限公司	含有阿斯匹林和维卡格雷的药用组合物
EP2796145B1 (en)	2013-04-22	2017-11-01	CSL Ltd.	A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge
KR101502588B1 (ko)	2013-05-01	2015-03-16	한국유나이티드제약 주식회사	클로피도그렐 및 아스피린의 복합제제
JP5905165B2 (ja) *	2013-08-02	2016-04-20	サノフイ	アセチルサリチル酸およびクロピドグレルを含む医薬錠剤
HUP1400294A2 (hu)	2014-06-13	2015-12-28	Skillpharm Kft	Clopidogrel új alkalmazása
CN107698620A (zh) *	2015-06-23	2018-02-16	江苏天士力帝益药业有限公司	一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) *	2020-08-14	2021-03-31	Алексей Викторович Марочков	Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
WO2023012479A1 (en)	2021-08-03	2023-02-09	Liqmeds Worldwide Limited	An oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2307538A1 (fr) *	1975-04-18	1976-11-12	Centre Etd Ind Pharma	Nouveau medicament anti-agregant plaquettaire

1996
- 1996-02-19 FR FR9602027A patent/FR2744918B1/fr not_active Expired - Fee Related
1997
- 1997-02-17 CA CA002246289A patent/CA2246289C/fr not_active Expired - Lifetime
- 1997-02-17 TR TR1998/01608T patent/TR199801608T2/xx unknown
- 1997-02-17 CZ CZ19982499A patent/CZ292363B6/cs not_active IP Right Cessation
- 1997-02-17 KR KR1019980706556A patent/KR100295345B1/ko not_active Ceased
- 1997-02-17 AU AU18844/97A patent/AU715655B2/en not_active Revoked
- 1997-02-17 EE EE9800247A patent/EE03513B1/et not_active IP Right Cessation
- 1997-02-17 RU RU98117511/14A patent/RU2184547C2/ru active
- 1997-02-17 NZ NZ331444A patent/NZ331444A/en not_active IP Right Cessation
- 1997-02-17 DE DE201012000030 patent/DE122010000030I2/de active Active
- 1997-02-17 AT AT97905218T patent/ATE218870T1/de active
- 1997-02-17 IL IL12584897A patent/IL125848A/xx not_active IP Right Cessation
- 1997-02-17 BR BR9707556A patent/BR9707556A/pt not_active IP Right Cessation
- 1997-02-17 SI SI9730355T patent/SI0881901T1/xx unknown
- 1997-02-17 JP JP52906097A patent/JP3662028B2/ja not_active Expired - Lifetime
- 1997-02-17 CN CN97192393A patent/CN1116042C/zh not_active Expired - Lifetime
- 1997-02-17 US US09/117,904 patent/US5989578A/en not_active Expired - Lifetime
- 1997-02-17 SK SK1105-98A patent/SK284285B6/sk not_active IP Right Cessation
- 1997-02-17 PT PT97905218T patent/PT881901E/pt unknown
- 1997-02-17 EP EP97905218A patent/EP0881901B1/fr not_active Expired - Lifetime
- 1997-02-17 HU HU9901144A patent/HU225036B1/hu active Protection Beyond IP Right Term
- 1997-02-17 WO PCT/FR1997/000296 patent/WO1997029753A1/fr not_active Ceased
- 1997-02-17 ES ES97905218T patent/ES2176684T3/es not_active Expired - Lifetime
- 1997-02-17 PL PL97327923A patent/PL187292B1/pl unknown
- 1997-02-17 DE DE69713287T patent/DE69713287T2/de not_active Expired - Lifetime
- 1997-02-17 UA UA98094800A patent/UA51695C2/uk unknown
- 1997-02-17 DK DK97905218T patent/DK0881901T3/da active
1998
- 1998-08-18 IS IS4827A patent/IS1892B/is unknown
- 1998-08-19 NO NO19983812A patent/NO317747B3/no not_active IP Right Cessation
2010
- 2010-07-09 NO NO2010015C patent/NO2010015I2/no unknown

Also Published As

Publication number	Publication date
BR9707556A (pt)	1999-07-27
HUP9901144A3 (en)	2001-04-28
SI0881901T1 (en)	2002-10-31
NO317747B3 (no)	2011-10-03
NO317747B1 (no)	2004-12-13
WO1997029753A1 (fr)	1997-08-21
FR2744918B1 (fr)	1998-05-07
EE03513B1 (et)	2001-10-15
IS4827A (is)	1998-08-18
CZ249998A3 (cs)	1998-11-11
ES2176684T3 (es)	2002-12-01
EE9800247A (et)	1999-02-15
DE69713287D1 (de)	2002-07-18
US5989578A (en)	1999-11-23
PT881901E (pt)	2002-09-30
FR2744918A1 (fr)	1997-08-22
IS1892B (is)	2003-10-20
CA2246289C (fr)	2003-12-16
AU1884497A (en)	1997-09-02
RU2184547C2 (ru)	2002-07-10
IL125848A0 (en)	1999-04-11
KR100295345B1 (ko)	2001-08-07
IL125848A (en)	2000-11-21
HUP9901144A2 (hu)	1999-09-28
CN1211922A (zh)	1999-03-24
NO983812D0 (no)	1998-08-19
SK110598A3 (en)	1999-01-11
DE122010000030I2 (de)	2012-06-21
CZ292363B6 (cs)	2003-09-17
AU715655B2 (en)	2000-02-10
CN1116042C (zh)	2003-07-30
CA2246289A1 (fr)	1997-08-21
DE69713287T2 (de)	2002-12-19
HU225036B1 (en)	2006-05-29
ATE218870T1 (de)	2002-06-15
HK1017850A1 (en)	1999-12-03
PL187292B1 (pl)	2004-06-30
EP0881901A1 (fr)	1998-12-09
DE122010000030I1 (de)	2010-10-21
NO2010015I2 (no)	2012-11-12
TR199801608T2 (xx)	1998-11-23
KR19990087163A (ko)	1999-12-15
JP3662028B2 (ja)	2005-06-22
JPH11510818A (ja)	1999-09-21
NO2010015I1 (no)	2010-07-26
NO983812L (no)	1998-10-09
NZ331444A (en)	2001-04-27
UA51695C2 (uk)	2002-12-16
SK284285B6 (sk)	2005-01-03
EP0881901B1 (fr)	2002-06-12
PL327923A1 (en)	1999-01-04

Publication	Publication Date	Title
DK0881901T3 (da)	2002-10-07	Kombination af aktive stoffer, der indeholder clopidogrel og et antithrombotisk middel
DE68925814D1 (de)	1996-04-04	Hydrogeniertes block-copolymer und dessen zusammensetzung
PT809498E (pt)	2004-06-30	Composicao farmaceutica para utilizacao topica contendo aciclovir e hidrocortisona
IS5409A (is)	2000-03-16	Útskipt karboxamídóþíasól, framleiðsla þeirra og lyfjablöndur sem innihalda þau
NO942835L (no)	1995-01-31	1-benzensulfonyl-1,3-dihydro-2H-benzimidazol-2-on-derivater, fremstilling derav og farmasöytiske blandinger som inneholder dem
DK0971717T3 (da)	2002-03-25	Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler
DK1112266T3 (da)	2003-09-15	Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
ZA9811445B (en)	1999-08-16	Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
NO950537L (no)	1995-08-15	Polysubstituerte 3-acylamino-5-fenyl-1,4-benzodiazepin-2-on-derivater, fremgangsmåter for fremstilling derav og farmasöytiske blandinger inneholdende dem
DE69808664D1 (de)	2002-11-14	Feuerfeste metall-silizid-legierung sputter-targets, dessen verwendung und herstellung
YU6401A (sh)	2004-03-12	Primena eletriptana za izradu leka za prevenciju učestanog javljanja migrene
DK0748222T3 (da)	2000-12-18	Hostestillende sammensætning, som indeholder hostestillende middel og benzydamin
IL110724A0 (en)	1994-11-11	Retroviral protease inhibitors, their preparation and pharmaceutical compositions containing them
DK0922703T3 (da)	2003-03-17	Substituerede heterocykliske benzocycloalkener og disses anvendelse som analgetisk virksomme stoffer
IT1294931B1 (it)	1999-04-23	Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
YU39598A (sh)	1999-09-27	Upotreba duloksetina i njegova farmaceutska smeša
PT1052991E (pt)	2003-08-29	Utilizacao de loperamida para o tratamento de infeccoes microbianas
IT9048605A0 (it)	1990-12-21	Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono.
ITMI911653A1 (it)	1992-12-17	Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ES1031864Y (es)	1996-07-16	Estructura modular perfeccionada para actividades deportivas, sociales y otras.
ITMI922832A1 (it)	1994-06-11	DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO.
ZA942972B (en)	1995-01-19	New quinoxalinedione derivatives, their production and use in pharmaceutical agents.